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Abstract
Several species of wild raptors have been found in Eurasia infected with highly pathogenic avian influenza virus (HPAIV)
subtype H5N1. Should HPAIV (H5N1) reach North America in migratory birds, species of raptors are at risk not only from
environmental exposure, but also from consuming infected birds and carcasses. In this study we used American kestrels as a
representative species of a North American raptor to examine the effects of HPAIV (H5N1) infection in terms of dose
response, viral shedding, pathology, and survival. Our data showed that kestrels are highly susceptible to HPAIV (H5N1). All
birds typically died or were euthanized due to severe neurologic disease within 4–5 days of inoculation and shed significant
amounts of virus both orally and cloacally, regardless of dose administered. The most consistent microscopic lesions were
necrosis in the brain and pancreas. This is the first experimental study of HPAIV infection in a North American raptor and
highlights the potential risks to birds of prey if HPAIV (H5N1) is introduced into North America.
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Introduction
Waterfowl (Anseriformes), gulls, and shorebirds (Charadrii-
formes) are the primary reservoirs of low pathogenic avian
influenza [1]. However, the role of wild birds in the ecology of
highly pathogenic avian influenza virus (HPAIV) H5N1 is unclear.
Many wild bird species have been found infected with HPAIV
(H5N1), usually associated with a mortality event, but whether
these species can act as reservoirs and if they have major roles
in the long distance movement of the virus remains to be
determined [2].
Wild waterfowl vary in their responses to infection with HPAIV
(H5N1). Some species shed large amounts of virus, yet exhibit little
to no obvious detrimental health effects [3]. On the other hand,
highly susceptible species such as various species of swans (Cygnus
spp.) and the wood duck (Aix sponsa), show 100% mortality within
days of inoculation with HPAIV (H5N1) [4,5].
One potential mechanism of HPAIV (H5N1) introduction into
North America would be migratory waterfowl or shorebirds
transporting the virus from Asia across the Bering Sea into
Alaska, from whence it could be further disseminated throughout
the continentbymigratorybirds.Speciesthat preyonorscavenge
sick or dying birds are also at risk of acquiring HPAIV (H5N1)
from their food, as well as from the environment [6]. Raptors
represent the apex of their food webs and thus, may be sensitive
indicators of HPAIV (H5N1) activity. Not only may their broad
geographic ranges make them susceptible to acquiring HPAIV
(H5N1) but the migratory nature of many species may also
contribute to long distance movement of HPAIV (H5N1). It is
noteworthy that several species of raptors have been found either
infected with, or dead from HPAIV (H5N1), including peregrine
falcon (Falco peregrinus), Saker falcon (Falco cherrug), Hodgson’s
hawk eagle (Spizaetus nipalensis), common kestrel (Falco tinnunculus),
buzzard (Buteo buteo), goshawk (Accipiter gentilis), and sparrowhawk
(Accipiter nisus) [7–11]. To the best of our knowledge, the only
controlled study examining the effects of HPAIV (H5N1)
infection in raptor species was an experimental vaccination trial
in captive gyr-saker falcon hybrids (F. rusticolis x F. cherrug)t h a t
showed that these birds were highly susceptible to HPAIV
(H5N1) [10].
In addition, many raptor species are highly visible, endangered
or threatened, and are politically and environmentally charismatic.
Therefore it is important to experimentally assess the effects of
HPAIV infection in raptor species to understand the potential
roles they have in AI ecology and to assess risks to their
populations. In this study, we experimentally inoculated American
kestrels (Falco sparverius) with various doses of HPAIV (H5N1) and
characterized infection in terms of survival, virus shedding, clinical
signs, and pathology, with the goals of understanding the response
of raptors to HPAIV infection and ultimately using American
kestrels as a model species of HPAIV (H5N1) infection in falcons
specifically, and raptors in general.
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7555Results
Clinical signs and mortality
All birds inoculated with virus died or showed severe clinical
signs and were euthanized within 7 days of inoculation, regardless
of dose administered (Figure 1). Clinical signs were similar in all
inoculated subjects, consisting of feather fluffing, rhythmic side to
side head movements, ataxia, head held at an angle, loss of
appetite, loss of balance and motor control, and tremors. Birds also
lost 8–10% of body mass in the 24 hours prior to death/
euthanasia. On average, infected birds died or were euthanized for
humane reasons between days 4–5 post-inoculation (DPI). There
were no overt signs of any respiratory or intestinal disease such as
dyspnea or diarrhea.
Virus shedding
Within 24 hours after inoculation with HPAIV, all exposed birds
were shedding virus orally (Table 1). Based on RT-PCR analysis,
the amount of viral RNA shed orally was consistent, peaked on DPI
1, and gradually declined until death/euthanasia. RT-PCR analysis
does not differentiate between viable, infectious virus and partial,
inactivated or defective virus inthe samples, therefore virusisolation
from all swabs was performed. Virus isolation in embryonated egg
culture showed that all oral swabs with measurable viral RNA had
infectious virus present (Table 1). There was no statistical difference
in shedding between doses (data not shown).
Cloacal shedding had a different profile, typically lagging a day
or more behind oral shedding before becoming detectable. The
quantities of virus RNA were lower, rose more gradually, peaked
on DPI 3–4, and declined more rapidly than oral shedding
(Table 2). One kestrel (2127), inoculated with the high viral dose,
shed similar amounts of viral RNA orally as other infected birds,
yet shed virus cloacally on only DPI 3 and survived the longest of
any subject inoculated (DPI 7). Many of the cloacal swabs,
especially ones with lower amounts of viral RNA as measured by
RT-PCR, did not have detectable infectious virus based on
embryonated egg culture.
Figure 1. Survival of American kestrels infected with highly
pathogenic avian influenza virus H5N1. Daily percentage of
American kestrels surviving after infection with one of three doses of
highly pathogenic avian influenza virus H5N1 (A/whooperswan/
Mongolia/244/05).
doi:10.1371/journal.pone.0007555.g001
Table 1. Oral shedding of highly pathogenic avian influenza virus H5N1 by experimentally.
infected American kestrels.
Day Post-inoculation (DPI)
Bird ID Sex Dose
1 DPI-0 DPI-1 DPI-2 DPI-3 DPI-4 DPI-5 DPI-6 DPI-7
2193 F 0 nc
2,3 nc nc nc nc nc nc nc
2 1 2 0 M 0 n c n cn c n c n cn c n c n c
2192 F 1 nc 22.8* 21.0* 21.3* 24.0*
2199 F 1 nc 24.8* 23.6* 22.5* 23.7*
2177 M 1 nc 22.7* 23.4* 27.6* 27.9*
2145 M 1 nc 20.1* 23.4 26.8* 27.0* 27.7*
2160 F 1 nc 26.7* 24.5* 24.7* 26.8*
2167 M 3 nc 21.1* 23.6* 24.1* 28.2* 23.1*
2162 F 3 nc 21.7* 22.9* 24.7* 25.0* 27.2* 28.2*
2130 M 3 nc 20.3* 25.7* 26.3* 27.8* 28.4*
1994 F 3 nc 21.1* 23.4* 26.7* 24.4* 25.2* 27.9*
2154 M 3 nc 19.7* 23.2* 25.0* 22.6*
2123 M 3 nc 21.7* 23.1* 24.7* 25.4*
2173 F 5 nc 20.5* 24.4* 22.7*
2194 F 5 nc 19.7* 24.3* 26.6* 26.4*
2189 M 5 nc 20.3 (3.0
4) 25.4 (2.4) 23.5 (3.2) 22.8 (3.2)
1992 M 5 nc 20.4* 22.3* 24.0* 25.9* 22.6*
2127 M 5 nc 21.8* 27.8* 31.2* 28.5* 28.2* 30.5* 28.3*
1Inoculation dose (log10 EID50/0.1 mL).
2nc= no Ct value obtained by H5 subtype specific RT-PCR analysis and confirmed in embryonated egg culture.
3Virus amounts represented as RT-PCR Ct values.
4Numbers in parentheses represent viral titers (log10 EID50/0.1 mL) as determined in embryonated egg culture.
*Presence of infectious virus confirmed by virus isolation in embryonated eggs.
doi:10.1371/journal.pone.0007555.t001
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All birds were seronegative to avian influenza before inocula-
tion. When possible, serum was collected from subjects immedi-
ately prior to euthanasia and analyzed by cELISA. Sera from all
birds euthanized before DPI 4 were seronegative, and of those sera
from birds that died on DPI 4, 3/5 (60%) had detectable
antibodies to AI, independent of dose. All sera obtained from DPI
5 or afterwards were seropositive (data not shown). These data
indicate that an immune response to HPAIV (H5N1), detectable
by commercially available cELISA, occurs relatively quickly (by
DPI 4–5) in infected birds. Because the kestrel colony where these
birds were obtained has a history of West Nile virus (WNV)
activity and infection with that virus could confound our analyses,
we also screened the sera for WNV antibodies by PRNT90. One
control kestrel (2193) was positive for WNV antibodies with a titer
of 1:320 and the rest of the birds were WNV seronegative. This
non-inoculated control kestrel that was seropositive for WNV
remained negative for HPAIV without any evidence of HPAIV
(H5N1) shedding or seroconversion.
Necropsy and Histopathology
Observable gross lesions were minimal, nonspecific and noted in
only 4 kestrels. The respective lesions in these four separate kestrels
were: 1) liver enlargement (approximately 1.25 times compared
with control birds) 2) slight enlargement of spleen (5 mm diameter
vs 3 mm in control birds); 3) congestion of the serosal surface of
the duodenum and 4) of the upper jejunum. The control birds had
noticeably greater amounts of mesenteric fat than all but one of
the inoculated kestrels. All other tissues appeared overtly normal.
All birds were examined histologically and a subset of tissues
was stained for influenza A antigen by immunohistochemistry.
Lesions observed in hematoxylin and eosin stained tissues were
most consistent in the brain and pancreas. All influenza virus
infected birds had meningitis and encephalitis ranging from mild,
acute, multifocal necrosis to regionally severe necrosis associated
with mild heterophilic inflammation (Fig. 2A). Lymphoplasma-
cytic perivascular cuffing was not a consistent finding but could be
severe when present. The location of encephalitis was inconsistent
between birds but taken together, was found in all regions of the
brain. Microscopic lesions were seen in pancreatic sections from
12/16 HPAIV (H5N1) infected kestrels. In five of those,
pancreatic lesions were mild and consisted of focal to multifocal
apoptosis of acinar cells. The remaining 7 kestrels with pancreatic
lesions had moderate to severe multifocal to coalescing pancreatic
necrosis (Fig. 2B). Heterophils were not a predominant finding and
when present were lightly scattered through the regions of
necrosis. Nonspecific mild lymphoplasmacytic periportal inflam-
mation and hepatocellular vacuolation were seen in 13 HPAIV
(H5N1) infected kestrels and one kestrel that died on 3 DPI had
multifocal acute hepatocellular necrosis accompanied by a mild
infiltrate of heterophils. Mild vacuolation and widening of
pulmonary interstitium was seen in 8 HPAIV (H5N1) infected
kestrels. In addition, 2 of these had mild and one had moderate
necrosis and heterophilic inflammation associated with airways.
All other tissues showed only mild and inconsistent pathology,
although every tissue type examined was affected in at least one or
more birds. There were no lesions in the control kestrel that was
seronegative for WNV. The kestrel that was seropositive for WNV
Table 2. Cloacal shedding of highly pathogenic avian influenza virus H5N1 by experimentally.
infected American kestrels.
Day Post-inoculation (DPI)
Bird ID Sex Dose
1 DPI-0 DPI-1 DPI-2 DPI-3 DPI-4 DPI-5 DPI-6 DPI-7
2193 F 0 nc
2,3 nc nc nc nc nc nc nc
2 1 2 0 M 0 n c n cn c n c n cn c n cn c
2192 F 1 nc nc 33.2* 36.4 36.6
2199 F 1 nc nc 35.1* 37.0 30.5*
2177 M 1 nc nc 37.4 38.5* 38.8
2145 M 1 nc nc 33.0* 29.0 32.2* 35.8
2160 F 1 nc nc 31.9* 34.6* 33.1
2167 M 3 nc nc 24.5* 25.5* 21.9* 24.9*
2162 F 3 nc 42.9 37.3* nc 37.6 nc nc
2130 M 3 nc nc 36.7* 38.3 38.4 nc
1994 F 3 nc 39.4 37.7* 40.6 40.7 38.7 40.6
2154 M 3 nc 41.8 32.9 33.5 28.9*
2123 M 3 nc nc 33.7* 35.1 33.9*
2173 F 5 nc 34.8* 24.7* 23.8*
2194 F 5 nc nc 33.0* 37.8 39.1
2189 M 5 nc 37.3 33.9* (1.4)
4 37.8* (1.0) 38.4
1992 M 5 nc 36.9 32.8* 34.3* 36.1 38.8
2127 M 5 nc nc nc 40.1 nc nc nc nc
1Inoculation dose (log10 EID50/0.1 mL).
2nc= no Ct value obtained by H5 subtype specific RT-PCR analysis and confirmed in embryonated egg culture.
3Virus amounts represented RT-PCR Ct values.
4Numbers in parentheses represent viral titers (log10 EID50/0.1 mL) as determined in embryonated egg culture.
*Presence of infectious virus confirmed by virus isolation in embryonated eggs.
doi:10.1371/journal.pone.0007555.t002
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meningitis, moderate lymphoplasmacytic myocarditis and inter-
stitial nephritis. Necrosis of one sheathed artery in the spleen and
non-specific mild periportal lymphoplasmacytic inflammation in
the liver with light hemosiderin-like pigment accumulation in
hepatocytes were also seen in the WNV seropositive kestrel.
Immunohistochemical staining was performed on tissues from 7
HPAIV (H5N1) infected kestrels. Tissues that had lesions
identified in hematoxylin and eosin stained tissues stained positive
for IHC influenza A antigen including brain and pancreas
(Fig. 2C,D), lung, liver, and kidney. All cell types were positive
in the regions of brain and lung involved. Acinar cells were the
primary antigen-staining cells in the pancreas. The foci of necrotic
hepatocytes stained positive for influenza A antigen in one liver
and IHC staining was confined to Kupffer cells and serosal cells in
another liver. The remaining 3/5 livers were negative. Influenza A
virus antigen staining in both medullary and cortical cells of the
adrenal gland was moderate in one of 5 birds and mild in another.
Spleens were negative for IHC detectable viral antigen in 2/5
birds with only scattered positive cells in the spleens of the other 3.
In addition, mild viral antigen staining was also present in, 2/3
trachea, 2/3 bone marrow, 4/6 heart. Although the outer
muscular wall and serosa stained faintly with IHC in intestinal
sections from 6/7 kestrels, antigen staining was seen in the mucosa
of only one bird, and this was faint and inconsistent.
Discussion
American kestrels were very susceptible to HPAIV (H5N1)
infection. With every dose, 100% of inoculated birds died or had
severe clinical signs and were euthanized within 7 days of
inoculation. Infection was systemic, a finding confirmed by
histological analyses of tissues. However, the most common
observable signs were characteristic of neurological disease. Brain
tissues had significant amounts of viral RNA and histology showed
prominent inflammation and necrosis, consistent with encephalitis.
All birds shed large amounts of virus orally and lesser amounts of
virus cloacally. Considering the findings that oral shedding
occurred earlier, was more consistent, and lasted longer than
cloacal shedding, these data confirm that surveillance systems for
HPAIV (H5N1) in raptors should include oral sampling, as has
been recommended for other species [12].
Kestrels infected with HPAIV (H5N1) consistently exhibited
clinical signs of central nervous system disease which has not been
previously reported in HPAIV (H5N1) infected falcons. Addition-
ally, in our study, a range of biologically relevant doses of virus was
examined. Because all inoculated birds died, regardless of dose, the
minimum infectious and lethal doses could not be calculated, but
was less than 10 EID50, the smallest virus dose administered. This
levelofexposurecouldreadilybeencounteredbywild birdsthrough
consumption of infected prey, contact with infected conspecifics, or
by contact with a HPAIV (H5N1) contaminated environment.
Should HPAIV (H5N1) reach North America, the risk to kestrel
populations is probably relatively minor given their feeding and
social behavior, the large geographic range, and relatively large
population size of this species. However, local kestrel populations
in the United States are declining for unknown reasons and may
have been negatively impacted by the introduction and spread of
West Nile virus [13]. The introduction of HPAIV (H5N1) could
have an additional negative impact on this species’ status.
Other species of raptors such as eagles, peregrine falcons,
accipiters, hawks, vultures, and California condors (Gymnogyps
Figure 2. Tissues from American kestrels experimentally inoculated with highly pathogenic avian influenza virus H5N1. A. Pancreas
with multifocal to coalescing areas of necrosis (arrows) (HE stain). B. Brain with multifocal cerebral necrosis (arrows) accompanied by a mild infiltration
of heterophils (HE stain). C. Section of same pancreatic tissue as in Fig. 2A, stained by immunohistochemistry to identify influenza A virus antigen.
Staining of influenza A antigen is intense in areas of necrosis (arrows). D. Immunohistochemical staining of influenza A virus antigen in brain tissue.
Areas of brain necrosis are strongly positive (arrows).
doi:10.1371/journal.pone.0007555.g002
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populations are much smaller and confined to more localized
geographic areas, would have greater risk of HPAIV (H5N1)
adversely impacting their populations. Raptors are the apex of
their food webs, effectively sampling sick, dying, or dead prey and,
thus, represent a natural surveillance system that likely targets
those subjects most likely to have had HPAIV exposure.
Traditional live-bird or hunter-killed waterfowl influenza surveil-
lance systems overwhelmingly sample healthy birds. Monitoring
raptor species, especially raptor mortality, may be an additional
method of surveillance for HPAIV (H5N1). Clearly, understand-
ing how HPAI would impact raptor species and the roles of these
species in the disease ecology of influenza is important and
warrants additional research. A captive breeding colony and the
corresponding ease of housing and handling make American
kestrels accessible and available in sufficient numbers for
experimental and/or vaccine studies without the expense of taking
birds from the wild. Thus, American kestrels may represent a
suitable model species for HPAIV (H5N1) infection studies in
falcons specifically and raptors in general.
Materials and Methods
Subjects
Immature American kestrels (4–5 months) were acquired from a
captive breeding colony at the USGS Patuxent Wildlife Research
Center, Laurel, MD and transported to the USGS National
Wildlife Health Center, Madison, WI. Birds were randomly
assigned to individual isolator cages (1/cage) in a Biosafety level 3+
facility and allowed to acclimate for 7 days with water and food
provided ad libitum. Birds were fed Nebraska Brand Bird of Prey
Diet (Central Nebraska Packing, Inc., North Platte, NE)
supplemented with a dead mouse every other day. All procedures,
housing, transport, and care were approved by the institutional
animal care and use committee.
Highly pathogenic avian influenza virus isolate and virus
inoculation
Kestrels were inoculated intranasally and intrachoanally with
one of three doses of HPAIV (H5N1) (A/whooperswan/
Mongolia/244/05) in a total volume of 100 ml. Two uninoculated
birds served as controls. Inocula were diluted in brain heart
infusion broth with penicillin/streptomycin and viral titers
confirmed by the method of Reed and Muench [14] in
embryonated chicken eggs [15]: 10
1.0 EID50/100 ml (5 birds),
10
3.0 EID50/100 ml (6 birds), 10
5.0 EID50/100 ml (5 birds).
Sampling
All birds were weighed daily and monitored as needed to
ascertain health status. Birds exhibiting severe disease signs,
especially neurological signs, were euthanized for humane reasons.
Serum samples were collected from all birds on day post-
inoculation (DPI) 0 and, when possible, immediately prior to
euthanasia by CO2 asphyxiation. Sera were stored at -20uC. Daily
cloacal and oropharyngeal swabs were taken using Dacron tipped
applicators, placed in cryovials containing viral transport media
(Hanks Balanced Salt Solution, 0.05% gelatin, 5% glycerin,
1500 U/mL penicillin, 1500 mg/mL streptomycin, 0.1 mg/mL
gentamicin, 1 mg/mL fungizone), and stored at 280uC until
analyses.
Serology
The pre-inoculation (day 0) and final serological status were
determined using the IDEXX Multi-Species ELISA kit according
to the manufacturer’s directions (IDEXX Laboratories, West-
brook, ME). Plaque reduction neutralization assays to detect West
Nile virus antibodies were performed according to the procedures
outlined in [16].
RNA extraction and real time reverse transcription
polymerase chain reaction (RT-PCR)
Viral RNA was extracted from cloacal and oropharyngeal
swabs using the MagMAX
TM-96 AI/ND Viral RNA Isolation Kit
(Ambion, Austin, TX) following the manufacturer’s procedures.
Real time RT-PCR was performed using the published proce-
dures, primers, and probe of Spackman et al. [17] for the detection
of HPAIV (H5N1). RT-PCR assays used reagents provided in the
Qiagen OneStep
H RT-PCR kit (Qiagen, Valencia, CA) and were
performed on a Stratagene Mx3005P thermal cycler.
Necropsy, immunohistochemical, and histological
analyses
All 16 inoculated kestrels and the two uninoculated controls
were examined at necropsy when, using sterile procedures,
portions of brain, trachea, lung, heart, liver, kidney, adrenal,
spleen, duodenum, pancreas, jejunum, cecal tonsil, and cloaca
with bursa of Fabricius were collected for histopathology. Tissues
were fixed in 10% neutral buffered formalin, embedded in
paraffin, sectioned at 5 mm, stained with hematoxylin and eosin,
and examined by light microscopy. Additional portions of brain,
intestine, liver, lung, spleen, and kidney were collected for RNA
extraction and RT-PCR analyses as described above.
Immunohistochemistry was processed at the Histology Labora-
tory, Department of Pathology, College of Veterinary Medicine,
University of Georgia. Following deparaffinization, proteinase K
was used for antigen retrieval and endogenous peroxidase was
blocked using 3% hydrogen peroxide (H312-500, Fisher Scientific,
Fair Lawn, NJ). Mouse monoclonal antibody to Influenza A virus
nucleoprotein (C65331M, Biodesign International, Saco, ME
1 mg/ml), diluted 1:200 using DakoH Antibody Diluent (S0809,
Dako, Carpinteria, CA), was applied to slides for 60 minutes. This
was followed by biotinylated horse anti-mouse IgG (BA-2001,
Vector Labs, Burlingame, CA) and streptavidin conjugated to
horseradish peroxidase (Dako’s LSABH 2; K1016, Dako, Carpin-
teria, CA). The substrate-chromogen system used was DAB
(K3466, Dako, Carpinteria, CA) and slides were counterstained
with Gills II hematoxylin. Positive tissue controls consisted of
formalin fixed, paraffin-embedded heart from avian influenza-
infected chicken. As a negative control, primary antibody was
substituted with Universal Negative Control (N1698, Dako,
Carpinteria, CA).
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